Clincosm LogoSign in Get a demo

Tuberculosis

Showing NaN - NaN of 33
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tuberculosis Trial in Worldwide (M72/AS01E-4 Mycobacterium tuberculosis investigational vaccine, Placebo)

Not yet recruiting
  • Tuberculosis
  • M72/AS01E-4 Mycobacterium tuberculosis investigational vaccine
  • Placebo
  • Bandung, Indonesia
  • +59 more
Sep 25, 2023

HIV I Infection, Tuberculosis Trial in South Africa (MTBVAC, BCG)

Not yet recruiting
  • HIV I Infection
  • Tuberculosis
  • MTBVAC
  • BCG
  • Westdene, Gauteng,, South Africa
  • +15 more
Jul 21, 2023

Tuberculosis Trial in Mozambique, South Africa, Tanzania (Sutezolid, N-acetyl cysteine, Pretomanid)

Not yet recruiting
  • Tuberculosis
  • Maputo, Mozambique
  • +3 more
Jan 13, 2023

Worse Outcome Post-Sars-CoV-2 Infection

Completed
  • COVID-19
  • +2 more
    • Johannesburg, Gauteng, South Africa
      The Aurum Institute
    Jan 9, 2023

    Tuberculosis, Multidrug-Resistant, Tuberculosis, Tuberculosis, Pulmonary Trial in Worldwide (Linezolid 600 mg, Linezolid 1200 mg

    Recruiting
    • Tuberculosis, Multidrug-Resistant
    • +2 more
    • Linezolid 600 mg
    • +7 more
    • Gaborone, South-East District, Botswana
    • +16 more
    Dec 13, 2022

    Tuberculosis, Rifampicin Resistant Tuberculosis Trial in Worldwide (Pretomanid, Optimized background regimen (OBR) for

    Not yet recruiting
    • Tuberculosis
    • Rifampicin Resistant Tuberculosis
    • Pretomanid
    • Optimized background regimen (OBR) for multidrug-resistant TB (MDR-TB
    • Rio De Janeiro, Brazil
    • +6 more
    Oct 18, 2022

    Tuberculosis Trial in Johannesburg (Pravastatin)

    Completed
    • Tuberculosis
    • Johannesburg, South Africa
      Chris Hani Baragwanath Hospital
    Sep 26, 2022

    Tuberculosis, HIV Trial in South Africa (VPM1002 Vaccine, BCG Vaccine, Placebo)

    Not yet recruiting
    • Tuberculosis
    • HIV Infections
    • VPM1002 Vaccine
    • +2 more
    • Johannesburg, Gauteng, South Africa
    • +8 more
    Sep 14, 2022

    Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Bedaquiline,

    Completed
    • Tuberculosis, Pulmonary
    • +4 more
    • Rio de Janeiro, Brazil
    • +25 more
    Jun 23, 2022

    Tuberculosis, HIV Trial in Haiti, India, South Africa (Bedaquiline)

    Recruiting
    • Tuberculosis
    • HIV Infections
    • Port-au-Prince, Haiti
    • +4 more
    Jun 15, 2022

    Tuberculosis, Pulmonary Tuberculosis, HIV Coinfection Trial in Johannesburg (Isoniazid, Rifampicin, Ethambutol)

    Recruiting
    • Tuberculosis
    • +2 more
    • Johannesburg, Gauteng, South Africa
      Tembisa Clinical Research Centre-The Aurum Institute
    Jun 8, 2022

    Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Linezolid,

    Active, not recruiting
    • Tuberculosis, Pulmonary
    • +5 more
    • Tbilisi, Georgia
    • +10 more
    Jan 26, 2022

    HIV, Tuberculosis Trial in Worldwide (Levonorgestrel (LNG))

    Completed
    Has Results
    • HIV Infections
    • Tuberculosis
    • Levonorgestrel (LNG)
    • Chicago, Illinois
    • +17 more
    Dec 22, 2021

    HIV, Tuberculosis Trial in Worldwide (Isoniazid (INH), Placebo for isoniazid (INH))

    Completed
    Has Results
    • HIV Infections
    • Tuberculosis
    • Isoniazid (INH)
    • Placebo for isoniazid (INH)
    • Gaborone, Botswana
    • +12 more
    Nov 3, 2021

    Tuberculosis, HIV Trial in Worldwide (Rifapentine (RPT), Isoniazid (INH), Pyridoxine (Vitamin B6))

    Completed
    Has Results
    • Tuberculosis
    • HIV Infections
    • Rifapentine (RPT)
    • +2 more
    • La Jolla, California
    • +44 more
    Nov 2, 2021

    HIV, Tuberculosis Trial in Worldwide (Efavirenz (EFV), Rifampin-containing anti-TB therapy)

    Completed
    • HIV Infections
    • Tuberculosis
    • Efavirenz (EFV)
    • Rifampin-containing anti-TB therapy
    • Pune, Maharashtra, India
    • +6 more
    Oct 28, 2021

    Tuberculosis, Pulmonary Tuberculosis Trial in Johannesburg (Pravastatin, Rifafour, Vitamin B6)

    Recruiting
    • Tuberculosis
    • Pulmonary Tuberculosis
    • Johannesburg, Gauteng, South Africa
      PHRU Non-Network CRS
    Oct 29, 2021

    Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Johannesburg, Port Elizabeth, Rustenburg

    Recruiting
    • Tuberculosis, Pulmonary
    • +4 more
    • Johannesburg, South Africa
    • +2 more
    Oct 4, 2021

    Tuberculosis Trial in Worldwide (rifapentine, rifapentine and moxifloxacin, control)

    Completed
    Has Results
    • Tuberculosis
    • San Francisco, California
    • +32 more
    Sep 1, 2021

    TB-CAPT MTB/XDR Study

    Recruiting
    • Tuberculosis
    • +2 more
    • Xpert MTB/XDR
    • Cape Town, South Africa
    • +1 more
    May 17, 2021

    Tuberculosis, Hiv Trial in Johannesburg, Soshanguve (Household contact tracing)

    Recruiting
    • Tuberculosis
    • Hiv
    • Household contact tracing
    • Johannesburg, South Africa
    • +1 more
    Feb 10, 2021

    Tuberculosis, Drug-resistant Tuberculosis Trial in Johannesburg (Contacts, Index)

    Completed
    • Tuberculosis
    • Drug-resistant Tuberculosis
    • Contacts
    • Index
    • Johannesburg, South Africa
    • +1 more
    Jan 7, 2021

    Tuberculosis Trial in Bellville 7530, Mowbray, Johannesburg (H56:IC31, Placebo)

    Completed
    Has Results
    • Tuberculosis
    • H56:IC31
    • Placebo
    • Bellville 7530, Cape Town, South Africa
    • +2 more
    Oct 28, 2019

    Evaluation of Centralised TB Assay Solutions

    Unknown status
    • Tuberculosis
    • Drug-resistant Tuberculosis
      • Tbilisi, Georgia
      • +5 more
      Oct 30, 2019

      Tuberculosis, HIV Trial in Johannesburg (rifapentine + isoniazid, Isoniazid)

      Completed
      • Tuberculosis
      • HIV
      • Johannesburg, Gauteng, South Africa
        The Aurum Institute NPC
      Oct 29, 2019